Utilising structural knowledge in drug design strategies: applications using Relibase

Area of Science:

• Biochemistry and Structural Biology
• Computational Chemistry
• Medicinal Chemistry

Background:

• Structure-based drug design relies on understanding molecular recognition, a complex field.
• Abundant protein structure data offers opportunities for novel insights.
• Identifying universal recognition rules and specific target determinants is crucial.

Purpose of the Study:

• To demonstrate how database query tools can enhance structure-based drug design.
• To explore critical aspects of drug design, including protein flexibility, water in binding pockets, and ligand specificity.
• To showcase the application of the Relibase system in analyzing molecular interactions.

Main Methods:

• Utilizing the Relibase database system for data analysis.
• Incorporating database query tools into the structure-based design workflow.
• Analyzing representative examples of protein-ligand interactions.

Main Results:

• Database query tools provide significant benefits to structure-based drug design.
• Key factors like protein flexibility, water molecules, and ligand specificity were analyzed.
• Relibase facilitates the search for preferred geometrical patterns in molecular fragments.

Conclusions:

• Integrating database query tools, such as Relibase, advances structure-based drug design.
• A deeper understanding of molecular recognition principles is facilitated by structural data analysis.
• Relibase aids in identifying critical factors for successful drug development.